Triage of women with ASCUS and LSIL cytology

BACKGROUND. The identification of a small percentage of high‐grade cervical intraepithelial neoplasias (HGCIN) among patients with minor cytological abnormalities (atypical squamous cells of undetermined significance [ASCUS] and/or low‐grade squamous intraepithelial lesions [LSIL] group) is a major...

Full description

Saved in:
Bibliographic Details
Published inCancer Vol. 111; no. 1; pp. 58 - 66
Main Authors Wentzensen, Nicolas, Bergeron, Christine, Cas, Frederic, Vinokurova, Svetlana, von Knebel Doeberitz, Magnus
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 25.02.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND. The identification of a small percentage of high‐grade cervical intraepithelial neoplasias (HGCIN) among patients with minor cytological abnormalities (atypical squamous cells of undetermined significance [ASCUS] and/or low‐grade squamous intraepithelial lesions [LSIL] group) is a major problem in cytology‐based cervical cancer screening. The authors investigated the efficacy of p16INK4a as a biomarker to identify samples of patients with HGCIN among those with an ASCUS or LSIL result in Papanicolaou cytology. METHODS. Consecutive liquid‐based cytology specimens of 137 ASCUS and 88 LSIL results were selected from gynecologists who adopted a triage regimen with biopsy under colposcopy 2 months later, independent of the p16INK4a result. p16INK4a stained slides were prepared and independently read by 2 observers, who used a recently described score to categorize p16INK4a stained squamous cells. The endpoint of the study was detection of a biopsy‐confirmed HGCIN. RESULTS. The overall sensitivity and specificity of p16INK4a positive cells with a nuclear score >2 for diagnosis of HGCIN in ASCUS and LSIL cases combined was 96% and 83%, respectively. The sensitivity and specificity in the ASCUS group was 95% and 84%, and 100% and 81% in the LSIL group, respectively. Two observers had a high concordance in assessing p16INK4a stained cells (κ value of 0.841). CONCLUSIONS. These data suggested that the use of p16INK4a as a biomarker combined with nuclear scoring of p16INK4a positive cells in cervical cytology to triage ASCUS and/or LSIL cases allows identification of HGCIN with good sensitivity and specificity. Cancer (Cancer Cytopathol) 2007. © 2006 American Cancer Society. The authors investigated the efficacy of p16INK4a as a biomarker to identify samples of patients with high‐grade cervical intraepithelial neoplasia among those with atypical squamous cells of undetermined significance or low‐grade squamous intraepithelial lesion result in Papanicolaou cytology.
AbstractList BACKGROUND. The identification of a small percentage of high‐grade cervical intraepithelial neoplasias (HGCIN) among patients with minor cytological abnormalities (atypical squamous cells of undetermined significance [ASCUS] and/or low‐grade squamous intraepithelial lesions [LSIL] group) is a major problem in cytology‐based cervical cancer screening. The authors investigated the efficacy of p16INK4a as a biomarker to identify samples of patients with HGCIN among those with an ASCUS or LSIL result in Papanicolaou cytology. METHODS. Consecutive liquid‐based cytology specimens of 137 ASCUS and 88 LSIL results were selected from gynecologists who adopted a triage regimen with biopsy under colposcopy 2 months later, independent of the p16INK4a result. p16INK4a stained slides were prepared and independently read by 2 observers, who used a recently described score to categorize p16INK4a stained squamous cells. The endpoint of the study was detection of a biopsy‐confirmed HGCIN. RESULTS. The overall sensitivity and specificity of p16INK4a positive cells with a nuclear score >2 for diagnosis of HGCIN in ASCUS and LSIL cases combined was 96% and 83%, respectively. The sensitivity and specificity in the ASCUS group was 95% and 84%, and 100% and 81% in the LSIL group, respectively. Two observers had a high concordance in assessing p16INK4a stained cells (κ value of 0.841). CONCLUSIONS. These data suggested that the use of p16INK4a as a biomarker combined with nuclear scoring of p16INK4a positive cells in cervical cytology to triage ASCUS and/or LSIL cases allows identification of HGCIN with good sensitivity and specificity. Cancer (Cancer Cytopathol) 2007. © 2006 American Cancer Society. The authors investigated the efficacy of p16INK4a as a biomarker to identify samples of patients with high‐grade cervical intraepithelial neoplasia among those with atypical squamous cells of undetermined significance or low‐grade squamous intraepithelial lesion result in Papanicolaou cytology.
Author Bergeron, Christine
Wentzensen, Nicolas
Vinokurova, Svetlana
Cas, Frederic
von Knebel Doeberitz, Magnus
Author_xml – sequence: 1
  givenname: Nicolas
  surname: Wentzensen
  fullname: Wentzensen, Nicolas
– sequence: 2
  givenname: Christine
  surname: Bergeron
  fullname: Bergeron, Christine
– sequence: 3
  givenname: Frederic
  surname: Cas
  fullname: Cas, Frederic
– sequence: 4
  givenname: Svetlana
  surname: Vinokurova
  fullname: Vinokurova, Svetlana
– sequence: 5
  givenname: Magnus
  surname: von Knebel Doeberitz
  fullname: von Knebel Doeberitz, Magnus
  email: knebel@med.uni‐heidelberg.de
BookMark eNotz99KwzAYBfAgE-ymNz5BHsDOL1-SprkcRd2gKNgK3oWYP7PStdIOSt9eN70659wc-C3Jouu7QMgtgzUDwHvXuWGNKBAuSMJAqxSYwAVJACBPpeDvV2Q5jl-_U6HkCbmrh8buA-0jnfpD6OjUHD_ppireKmo7T8tqV1I3H_u238_X5DLadgw3_7ki9eNDXWzT8uVpV2zK1OUcUh8i8-Cj9JFxHbOQC8ajzCDjqFFJBS7DEFCDcE6h5d7GqJWKTFuvsw--IuzvdmraMJvvoTnYYTYMzMloTkZzNpriuXg9N_4DGGtHAg
CitedBy_id crossref_primary_10_1002_dc_21349
crossref_primary_10_1016_S1470_2045_08_70208_0
crossref_primary_10_1186_1742_6413_4_7
crossref_primary_10_11144_Javeriana_umed61_1_dual
crossref_primary_10_3892_etm_2011_316
crossref_primary_10_1002_ijc_24774
crossref_primary_10_18231_j_ijpo_2022_055
crossref_primary_10_1111_cyt_12083
crossref_primary_10_1016_j_pog_2011_01_007
crossref_primary_10_1016_j_ajog_2008_12_025
crossref_primary_10_4103_am_am_17_20
crossref_primary_10_1007_s00105_009_1809_y
crossref_primary_10_1016_j_pog_2009_12_003
crossref_primary_10_1002_dc_21270
crossref_primary_10_1158_1055_9965_EPI_08_0508
crossref_primary_10_1007_s00292_012_1613_9
crossref_primary_10_1093_jnci_djq562
crossref_primary_10_1002_cncy_20078
crossref_primary_10_1158_1055_9965_EPI_08_0306
crossref_primary_10_1016_j_ctrv_2008_10_005
crossref_primary_10_1155_2012_289315
crossref_primary_10_1155_2020_6878761
crossref_primary_10_1097_PAT_0000000000000249
crossref_primary_10_1007_s00120_011_2693_5
crossref_primary_10_1002_ijc_30783
crossref_primary_10_3238_arztebl_2008_0617
crossref_primary_10_1016_S1386_6532_09_70006_X
crossref_primary_10_1016_S1470_2045_08_70238_9
crossref_primary_10_5301_tj_5000524
crossref_primary_10_1177_039463201102400219
crossref_primary_10_1586_eog_11_13
crossref_primary_10_1002_cncy_20140
crossref_primary_10_1002_cncy_20143
crossref_primary_10_1002_cncy_21473
crossref_primary_10_1007_s00129_007_1966_y
crossref_primary_10_1002_cncy_21233
crossref_primary_10_1002_cncy_21511
crossref_primary_10_1016_j_ygyno_2010_06_011
crossref_primary_10_1097_IGC_0b013e3182009eea
crossref_primary_10_4155_bio_13_233
crossref_primary_10_1002_ijc_26017
crossref_primary_10_1111_j_1582_4934_2008_00631_x
crossref_primary_10_1016_S1470_2045_12_70529_6
crossref_primary_10_1002_jmv_23310
crossref_primary_10_1128_JCM_00181_12
crossref_primary_10_1002_dc_20822
crossref_primary_10_1002_dc_21757
crossref_primary_10_1016_j_gyobfe_2008_03_016
crossref_primary_10_1002_ijc_27750
crossref_primary_10_1002_dc_21758
crossref_primary_10_1002_cncy_21205
crossref_primary_10_4103_1742_6413_76379
crossref_primary_10_1007_s00428_018_2432_z
crossref_primary_10_1309_AJCP3CD9YKYFJDQL
crossref_primary_10_1002_cncy_22103
crossref_primary_10_1155_2012_507286
crossref_primary_10_1158_1055_9965_EPI_09_0328
ContentType Journal Article
Copyright Copyright © 2006 American Cancer Society
Copyright_xml – notice: Copyright © 2006 American Cancer Society
DOI 10.1002/cncr.22420
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-0142
EndPage 66
ExternalDocumentID CNCR22420
Genre article
GrantInformation_xml – fundername: University of Heidelberg
GroupedDBID ---
-~X
.3N
.GA
.Y3
05W
0R~
10A
1CY
1L6
1OC
24P
29B
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
6J9
6P2
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
85S
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AARRQ
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABHFT
ABIJN
ABIVO
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACNCT
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AGNAY
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C1A
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
E3Z
EBS
EJD
EX3
F00
F01
F04
F5P
FD6
FUBAC
G-S
G.N
GNP
GODZA
GX1
H.X
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
J0M
J5H
JPC
KBYEO
KQQ
KZ1
L7B
LATKE
LAW
LC2
LC3
LH4
LITHE
LMP
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NEJ
NF~
NNB
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SJN
SUPJJ
TEORI
UDS
UHB
V2E
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
XPP
XV2
Z0Y
ZGI
ZZTAW
~IA
~WT
ID FETCH-LOGICAL-c830-def1d0df5df139f6e8413f560632927570c62ee2904cc72a3daff977f19ad96b3
IEDL.DBID DR2
ISSN 0008-543X
IngestDate Sat Aug 24 00:50:40 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c830-def1d0df5df139f6e8413f560632927570c62ee2904cc72a3daff977f19ad96b3
Notes The excellent technical assistance of Denise Eschenbach and Nina Hensch is gratefully acknowledged.
Magnus von Knebel Doeberitz is a shareholder, advisor to, and member of the board of MTM Laboratoies AG, a company that develops and markets products related to the scientific content of this article.
Fax:(011) 49‐6221‐565981
PageCount 1
ParticipantIDs wiley_primary_10_1002_cncr_22420_CNCR22420
PublicationCentury 2000
PublicationDate 25 February 2007
PublicationDateYYYYMMDD 2007-02-25
PublicationDate_xml – month: 02
  year: 2007
  text: 25 February 2007
  day: 25
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
PublicationTitle Cancer
PublicationYear 2007
Publisher Wiley Subscription Services, Inc., A Wiley Company
Publisher_xml – name: Wiley Subscription Services, Inc., A Wiley Company
References 2002; 38
2001; 92
2004; 122
2001; 93
2004; 445
2004; 102
2004; 48
1996; 93
2000; 95
2003; 16
2003; 95
2006; 118
1998; 153
2004; 10
2004; 96
2002; 26
2006; 108
2003; 127
2005; 105
2004; 13
2003; 47
2005; 97
1996; 334
2003; 189
2003; 188
References_xml – volume: 96
  start-page: 280
  year: 2004
  end-page: 293
  article-title: Virologic versus cytologic triage of women with equivocal Pap smears: a meta‐analysis of the accuracy to detect high‐grade intraepithelial neoplasia
  publication-title: J Natl Cancer Inst.
– volume: 188
  start-page: 1383
  year: 2003
  end-page: 1392
  article-title: Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance
  publication-title: Am J Obstet Gynecol.
– volume: 95
  start-page: 46
  year: 2003
  end-page: 52
  article-title: Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10‐year cohort analysis
  publication-title: J Natl Cancer Inst.
– volume: 189
  start-page: 295
  year: 2003
  end-page: 304
  article-title: 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia
  publication-title: Am J Obstet Gynecol.
– volume: 48
  start-page: 771
  year: 2004
  end-page: 782
  article-title: Morphologic characteristics of p16 ‐positive cells in cervical cytology samples
  publication-title: Acta Cytol.
– volume: 47
  start-page: 753
  year: 2003
  end-page: 761
  article-title: Performance of a new, liquid‐based cervical screening technique in the clinical setting of a large French laboratory
  publication-title: Acta Cytol.
– volume: 153
  start-page: 1741
  year: 1998
  end-page: 1748
  article-title: Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions
  publication-title: Am J Pathol.
– volume: 93
  start-page: 4350
  year: 1996
  end-page: 4354
  article-title: Inhibition of cyclin D‐CDK4/CDK6 activity is associated with an E2F‐mediated induction of cyclin kinase inhibitor activity
  publication-title: Proc Natl Acad Sci U S A.
– volume: 108
  start-page: 119
  year: 2006
  end-page: 123
  article-title: Role of P16((INK4a)) expression in identifying CIN2 or more severe lesions among HPV‐positive patients referred for colposcopy after abnormal cytology
  publication-title: Cancer.
– volume: 334
  start-page: 1030
  year: 1996
  end-page: 1038
  article-title: Cancer of the uterine cervix
  publication-title: N Engl J Med.
– volume: 122
  start-page: 894
  year: 2004
  end-page: 901
  article-title: The predictive value of p16 (INK4a) and hybrid capture 2 human papillomavirus testing for high‐grade cervical intraepithelial neoplasia
  publication-title: Am J Clin Pathol.
– volume: 127
  start-page: 946
  year: 2003
  end-page: 949
  article-title: Findings to date from the ASCUS‐LSIL Triage Study (ALTS)
  publication-title: Arch Pathol Lab Med.
– volume: 93
  start-page: 293
  year: 2001
  end-page: 299
  article-title: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial
  publication-title: J Natl Cancer Inst.
– volume: 97
  start-page: 35
  year: 2005
  end-page: 40
  article-title: Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance‐categorized Pap smear? A comparative analysis using abnormal cervical smears with follow‐up biopsies
  publication-title: Gynecol Oncol.
– volume: 95
  start-page: 821
  year: 2000
  end-page: 827
  article-title: Human papillomavirus testing in women with mild cytologic atypia
  publication-title: Obstet.Gynecol.
– volume: 26
  start-page: 1389
  year: 2002
  end-page: 1399
  article-title: p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia
  publication-title: Am J Surg Pathol.
– volume: 102
  start-page: 100
  year: 2004
  end-page: 108
  article-title: Usefulness of liquid‐based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials
  publication-title: Cancer.
– volume: 13
  start-page: 1355
  year: 2004
  end-page: 1360
  article-title: Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population‐based cohort in Costa Rica
  publication-title: Cancer Epidemiol Biomarkers Prev.
– volume: 105
  start-page: 461
  year: 2005
  end-page: 467
  article-title: Evaluation of a nuclear score for p16INK4a‐stained cervical squamous cells in liquid‐based cytology samples
  publication-title: Cancer.
– volume: 118
  start-page: 1254
  year: 2006
  end-page: 1260
  article-title: Immunocytochemistry in liquid‐based cervical cytology: analysis of clinical use following a cross‐sectional study
  publication-title: Int J Cancer.
– volume: 16
  start-page: 665
  year: 2003
  end-page: 673
  article-title: p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki‐67 expression and detection of high‐risk HPV types
  publication-title: Mod Pathol.
– volume: 38
  start-page: 2229
  year: 2002
  end-page: 2242
  article-title: New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections
  publication-title: Eur J Cancer.
– volume: 10
  start-page: 2407
  year: 2004
  end-page: 2414
  article-title: Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer
  publication-title: Clin Cancer Res.
– volume: 92
  start-page: 276
  year: 2001
  end-page: 284
  article-title: Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri
  publication-title: Int J Cancer.
– volume: 445
  start-page: 616
  year: 2004
  end-page: 620
  article-title: p16INK4a expression and progression risk of low‐grade intraepithelial neoplasia of the cervix uteri
  publication-title: Virchows Arch.
SSID ssj0007253
Score 1.8822209
Snippet BACKGROUND. The identification of a small percentage of high‐grade cervical intraepithelial neoplasias (HGCIN) among patients with minor cytological...
SourceID wiley
SourceType Publisher
StartPage 58
SubjectTerms ASCUS
biomarker
cervical screening
human papillomavirus (HPV)
liquid‐based cytology
LSIL
p16INK4a
triage
Title Triage of women with ASCUS and LSIL cytology
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcncr.22420
Volume 111
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1JSwMxFMdD8SBe3MWdHDyJaTOZyWQGvJTRUqX20AV6kSGrB2EqtT3UT2-WaYve9BZIAnlkef-8JL8AcEM8lI1wlKRCo0SbBHFtdylZxDHPTWZYoH320-44eZ7QSQPcr97CBD7EOuDmZoZfr90E5-KztYGGykrOmtYBEbdhj2Lm7nM9DDbsKEZqBCXOEE3iyZpNSlqbqj8lqfcpnT3wumpNuEry3lzMRVN-_QI1_re5-2C3FpuwHUbHAWjo6hBsv9TH6UfgbmSH35uGUwM9iQG6qCxsD4vxEPJKwd7wqQfl0n9xuzwGo87jqOii-vsEJLMYI6VNpLAyVBmr8kyqM-uvjBU4aUxywijDMiVakxwnUjLCY8WNsWrQRDlXeSriE7BVTSt9CqB7P2vzc2W1R2KzBBPW9VGCU8Gk4PQM3HrTy49AyCgDC5mUzujSG10W_WLgU-d_KXwBdkIwlSBCL8HWfLbQV1YFzMW17-1v2qurJw
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ07T8MwEMctVCRg4Y1444EJ4TZ1HDsZq0DVQtqhTaVukZ8MSCkq7VA-PbYTtYINtkiOpZzsy_19tn8HwD32UDbMEaFCI6INQVzbVUrc5gFPTGxYRfsc0t6EvEyjaX02x92FqfgQ64Sb8wz_v3YO7hLSrQ01VJZy3rQRCNsV-7b199AVMHgabehRDNcQyiBGEQmnazopbm36_hSlPqp0D6rSqZ8eRugOk7w3lwvRlF-_UI3__uBDsF_rTdipJsgR2NLlMdgZ1DvqJ-AxtzPwTcOZgR7GAF1iFnbG6WQMealgNu5nUK58ldvVKci7z3naQ3UFBSTjMEBKm7YKlImUsULPUB3bkGWsxqEhTjCLWCAp1honAZGSYR4qbowVhKadcJVQEZ6BRjkr9TmA7gqtbU-UlR_ENgkmbPSLcEAFk4JHF-DB2158VJCMosIh48IZXXiji3SYjvzT5V9evgO7vXyQFVl_-HoF9qrcKkY4ugaNxXypb6woWIhbP_TfsZSvQQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3LS8MwHMfDmDC8-Bbf5uBJzJaladqCl9FZNp1D9oBdpOTpQejG2A7zrzdNuw296S2QBPIjj983vySfAHBHHJSNcESZ0IhqQxHXdpcSNjnmkQlNUNA--6wzps8Tf1IBj-u3MAUfYhNwy2eGW6_zCT5TprGFhspMzuvWARG7Yd-hzMP5ha72YAuPCkjJoMQh8qk32cBJSWNb96cmdU4l2Qfv6-YUd0k-68uFqMuvX6TG_7b3AOyVahO2iuFxCCo6OwK11_I8_Rg8jOz4-9BwaqBDMcA8LAtbw3g8hDxTsDfs9qBcuT9uVydglDyN4g4q_09AMvQwUto0FVbGV8bKPMN0aB2WsQqHeSQigR9gyYjWJMJUyoBwT3FjrBw0zYiriAnvFFSzaabPAMwf0Nr8SFnxQW2WCIT1fT7BTARScP8c3DvT01mByEgLGDJJc6NTZ3Qa9-OBS138pfAtqL21k7TX7b9cgt0isEoQ8a9AdTFf6murCBbixnX8N-SSrfA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Triage+of+women+with+ASCUS+and+LSIL+cytology&rft.jtitle=Cancer&rft.au=Wentzensen%2C+Nicolas&rft.au=Bergeron%2C+Christine&rft.au=Cas%2C+Frederic&rft.au=Vinokurova%2C+Svetlana&rft.date=2007-02-25&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0008-543X&rft.eissn=1097-0142&rft.volume=111&rft.issue=1&rft.spage=58&rft.epage=66&rft_id=info:doi/10.1002%2Fcncr.22420&rft.externalDBID=10.1002%252Fcncr.22420&rft.externalDocID=CNCR22420
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-543X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-543X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-543X&client=summon